日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An ingestible device for automated sampling and location tracing in gastrointestinal tract

一种用于胃肠道自动采样和定位追踪的可摄入式装置

Li, Tao; Felton, Jeremy; Lewis, Johnathan; Cheng, Qisen; Meredith, Ryan; Lu, Hsueh-Tsung; Benken, Alexander; Dutta, Partha P; Liao, Jinhui; Zhao, Xiangyu D; Matvekas, Aleksas; Baker, Jason; Hasler, William L; Babiskin, Andrew; Walenga, Ross; Fang, Lanyan Lucy; Lionberger, Robert; Pai, Manjunath P; Sun, Duxin; Gianchandani, Yogesh B

Morphomics-informed population pharmacokinetic and physiologically-based pharmacokinetic modeling to optimize cefazolin surgical prophylaxis

基于形态组学和生理学的群体药代动力学模型优化头孢唑林手术预防

Liu, Shuhan; Matvekas, Aleksas; Naimi, Tamara; Ghanem, Aws; Li, Ruiting; Rajanayake, Krishani; Derstine, Brian; Ross, Brian; Sullivan, June; Yun, Hyun Gi; Regenbogen, Scott; Byrn, John; Su, Grace; Wang, Stewart; Pai, Manjunath P

Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer.

发现 ARD-2585 是一种效力极强且口服有效的 PROTAC 雄激素受体降解剂,可用于治疗晚期前列腺癌

Xiang Weiguo, Zhao Lijie, Han Xin, Qin Chong, Miao Bukeyan, McEachern Donna, Wang Yu, Metwally Hoda, Kirchhoff Paul D, Wang Lu, Matvekas Aleksas, He Miao, Wen Bo, Sun Duxin, Wang Shaomeng

Alteration in Acute Kidney Injury Potential with the Combination of Vancomycin and Imipenem-Cilastatin/Relebactam or Piperacillin/Tazobactam in a Preclinical Model

在临床前模型中,万古霉素联合亚胺培南-西司他丁/瑞巴坦或哌拉西林/他唑巴坦可改变急性肾损伤的发生率

He, Miao; Souza, Ernane; Matvekas, Aleksas; Crass, Ryan L; Pai, Manjunath P

Panobinostat penetrates the blood-brain barrier and achieves effective brain concentrations in a murine model

帕比司他能穿过血脑屏障,并在小鼠模型中达到有效的脑浓度。

Homan, Morgan J; Franson, Andrea; Ravi, Karthik; Roberts, Holly; Pai, Manjunath P; Liu, Cai; He, Miao; Matvekas, Aleksas; Koschmann, Carl; Marini, Bernard L